Clinical studies are
much safer
than you think.

Sophie, 24, Quebec City Sales Rep participated four times in our studies and would gladly do so again.

Find out more information about our clinical studies »»»

Learn about our
Refer-a-friend program.

You can receive up to $250 for each participant you recommend who meets our enrollment criteria.

Learn more about our program's terms and conditions »»»

Clinical studies are
much safer than you think.

David, 21, a student from Sainte-Foy,
participated in three of our studies and would not hesitate to sign up for more.

Find out more information about our clinical studies »»»

Ensuring participant
security
is our top priority.

Tests are supervised by teams of experienced physicians, nurses and technicians. Regulatory authorities, such as Health Canada, regularly review the procedures.

Learn why you might want to participate in our studies »»»

Current Studies

Tue. 26-Aug-14 - Fri. 23-Jan-15 Male or Female | Ages 25-55 | Smokers or Non-smokers $6,025
A study to evaluate the safety, tolerability, absorption and the elimination of an investigational drug used for the treatment of disorders involving the complement system.
Sun. 17-Aug-14 - Sat. 04-Oct-14 Female | Ages 18 to 45 years old | Smokers or Non-smokers $ 7500
The goal of this study is to compare doxylamine-pyridoxin delayed-release 10 mg-10 mg tablets with the new 20 mg-20 mg doxylamine-pyridoxine delayed-release tablet to see if there are differences in how much drug is taken up by the body and how quickly.
Mon. 11-Aug-14 - Tue. 21-Oct-14 Male | Ages 18-65 | Smokers or Non-smokers $ 6,000
A study to evaluate the safety, tolerability, absorption and the elimination of an investigational drug designed for the treatment of testosterone (male hormone) deficiencies in men.
Sun. 10-Aug-14 - Mon. 29-Sep-14 Male or Female | Ages 18-50 | Smokers or Non-smokers $ 1,570
A study to compare the rate and extent of absorption of an investigational drug versus a reference drug which is a supplemental hormone used as replacement or supplemental therapy in persons in whom the thyroid gland doesn’t function properly.
Mon. 04-Aug-14 - Tue. 16-Sep-14 Male or Female | Ages 18-55 | Non-smoker $ 3,350
A study to evaluate the safety, tolerability, absorption and the elimination of an investigational drug used for the treatment of hypophosphatasia.
Sun. 03-Aug-14 - Wed. 03-Sep-14 Male | Ages 18 to 65 years old | Non-smoker $ 2560
The goal of this study is to compare atorvastatin tablets from 2 different companies, to see if there are differences in how much drug is taken up by the body and how quickly.
Sun. 03-Aug-14 - Wed. 03-Sep-14 Male | Ages 18 to 65 years old | Non-smoker $ 2560
The goal of this study is to compare atorvastatin tablets from 2 different companies, to see if there are differences in how much drug is taken up by the body and how quickly.
Thu. 31-Jul-14 - Fri. 08-Aug-14 Male | Ages 18+ | Non-smoker $ 900
A study to compare the rate and extent of absorption of an investigational drug versus a reference drug used in the treatment of parkinson's disease.
Thu. 19-Jun-14 - Sat. 28-Jun-14 Male | Ages 18-55 | Non-smoker $ 900
A study to compare the rate and extent of absorption of an investigational drug versus a reference drug used for the treatment of pulmonary hypertension.

See All Current Studies